Frustration incorporated: Revealing a natural strategy for making 'superior' materials
Peer-Reviewed Publication
Thinking creatively, solving complex problems, and working in teams… all add up to Design Thinking (DT). A study conducted by the Escuela Superior Politécnica del Litoral (ESPOL) and Ghent University provides a step-by-step guide for teaching this methodology as a university course.
The main objective of this study is to share the implementation of DT in the first year of all undergraduate programs at ESPOL, considering that previous research has shown that this course fosters essential DT skills in a world of constant change, allowing students to build their own knowledge through experiential learning.
Twelve distinguished science and health journalists have been awarded a highly competitive fellowship in the Logan Science Journalism Program at the Marine Biological Laboratory (MBL). Now in its 38th year, the Logan Science Journalism Program provides journalists with immersive, hands-on research training, giving them invaluable insight into the practice of science as well as some of the major news stories of today
NIST researchers have found special atomic patterns called quasicrystals in 3D-printed aluminum alloys.
Quasicrystals increase the strength of 3D-printed aluminum, the researchers discovered, making it possible to use in lightweight, high-strength objects such as airplane parts.
Once thought impossible, quasicrystals were originally discovered at NIST, leading to a 2011 Nobel Prize in Chemistry.
The Food and Drug Administration (FDA) collects user fees from drug and medical device companies to fund its work ensuring the safety of these products. Creating a similar program that collects fees from food companies could generate much-needed resources to strengthen the FDA’s oversight of foods, according to a new legal and policy analysis published in the journal Health Affairs.
Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to inflammation. It’s the most inflammatory of the interstitial lung diseases (ILDs), a family of conditions that all involve some level of inflammation and fibrosis, or scarring, of the lungs. In the U.S., pulmonary sarcoidosis affects around 200,000 patients. The cause is unknown, and no new treatments have been introduced in the past 70 years. In a paper published in Science Translational Medicine on March 12, 2025, scientists at Scripps Research and aTyr Pharma characterized a protein, HARSWHEP, that can soothe the inflammation associated with sarcoidosis by regulating white blood cells. Reducing inflammation slows the disease’s progression and results in less scarring. A phase 1b/2a clinical trial of efzofitimod, a therapeutic form of HARSWHEP, showed promising results.
A web platform developed at Emory University uses a chatbot to enable any chemist — including undergraduate chemistry majors — to configure and execute complex quantum mechanical simulations through chatting.